KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 141 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,000 | -33.3% | 685 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 685 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | -70.0% | 685 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $10,000 | +11.1% | 685 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $9,000 | -18.2% | 685 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $11,000 | – | 685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |